by Kall Kwik WGC | May 30, 2016 | Free Library
May, 2016 SMM-143 A Frugal Future Looking at the future of the life science industry, it’s evident that value will dominate the industry environment. As a result, free-spending life science companies will be replaced by frugal, ruthlessly...
by Kall Kwik WGC | Apr 29, 2016 | Free Library
April, 2016 SMM-142 GSK’s Morality Gene GSK’s recent decisions about pricing, transparency and return on investment seem to indicate an interesting new adaption to market conditions, one that is likely to be followed by the industry. This...
by Kall Kwik WGC | Mar 23, 2016 | Free Library
March, 2016 SMM-141 Sexual selection By focusing on a particular trait when we interview candidates for a position in our organisation, we may open ourselves up to unintended consequences, neglecting the full range of routines we...
by Kall Kwik WGC | Mar 9, 2016 | Free Library
February, 2016 SMM-140 Under Pressure There are six inexorable forces shaping the evolution of pharma and medtech. Asking and answering the questions about what selection pressures are acting in our industry is the first step in predicting how...
by Kall Kwik WGC | Mar 9, 2016 | Free Library
February, 2016 SMM-139 J&J’s Portent of Purity There is a new pattern of shareholder pressure across the sector, leading to new corporate structures being seen to emerge.
by Kall Kwik WGC | Jan 26, 2016 | Free Library
January, 2016 SMM-138 Not as we know it When it comes to evolution in industry, we need to think bout how the patient need will be met in future and evolve accordingly.
